» Articles » PMID: 11239412

The Genetic Basis for Cardiomyopathy: from Mutation Identification to Mechanistic Paradigms

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2001 Mar 10
PMID 11239412
Citations 325
Authors
Affiliations
Soon will be listed here.
Citing Articles

A gradient of force generation at rest differentiates cardiomyopathy outcomes with variants of actin located at the same residue.

Jones M, Tran C, Singh J, Dawson J J Mol Cell Cardiol Plus. 2025; 2():100023.

PMID: 39802493 PMC: 11708414. DOI: 10.1016/j.jmccpl.2022.100023.


From amoeboid myosin to unique targeted medicines for a genetic cardiac disease.

Spudich J Front Physiol. 2024; 15:1496569.

PMID: 39529926 PMC: 11550953. DOI: 10.3389/fphys.2024.1496569.


Safety and Effectiveness of Mavacamten Use in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.

Alharbi T, Alnadawi H, Almutairi G, Altheyab F, Aldoweesh O, Alfehaid O Cureus. 2024; 16(9):e70550.

PMID: 39479079 PMC: 11524545. DOI: 10.7759/cureus.70550.


Predictors of trastuzumab-induced cardiotoxicity among racially and ethnically diverse patients with HER2-positive breast cancer.

Vaynrub A, Mishalani L, Raikhelkar J, Crew K Cardiooncology. 2024; 10(1):68.

PMID: 39396009 PMC: 11470559. DOI: 10.1186/s40959-024-00272-8.


Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Spudich J, Nandwani N, Robert-Paganin J, Houdusse A, Ruppel K EMBO J. 2024; 43(19):4139-4155.

PMID: 39192034 PMC: 11445530. DOI: 10.1038/s44318-024-00199-x.